Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


09.04.2018

1 Am J Respir Crit Care Med
3 Ann Oncol
2 Ann Thorac Surg
2 Arch Pathol Lab Med
1 BMC Cancer
1 Cancer Sci
2 Clin Cancer Res
2 Int J Oncol
4 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
1 J Clin Invest
1 J Thorac Cardiovasc Surg
1 J Thorac Oncol
1 Lung Cancer (Auckl)
1 N Engl J Med
2 Oncogene
2 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. YAMAUCHI Y, Safi S, Blattner C, Rathinasamy A, et al
    Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer.
    Am J Respir Crit Care Med. 2018 Apr 4. doi: 10.1164/rccm.201708-1707.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. DEROSA L, Hellmann MD, Spaziano M, Halpenny D, et al
    Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small cell lung cancer.
    Ann Oncol. 2018 Mar 30. pii: 4956695. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. MULLER DC, Hodge AM, Fanidi A, Albanes D, et al
    No association between circulating concentrations of vitamin D and risk of lung cancer: An analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).
    Ann Oncol. 2018 Apr 2. pii: 4958387. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. TAO MH, Chen S, Freudenheim JL, Cauley JA, et al
    Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
    Ann Oncol. 2018 Mar 29. pii: 4956655. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. SHIONO S, Endo M, Suzuki K, Yarimizu K, et al
    Spread Through Air Spaces is a Prognostic Factor in Sublobar Resection of Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2018 Apr 3. pii: S0003-4975(18)30417.
    PubMed     Text format     Abstract available

  6. BECK N, Hoeijmakers F, van der Willik EM, Heineman DJ, et al
    National Comparison of Hospital Performances in Lung Cancer Surgery: The Role Of Casemix Adjustment.
    Ann Thorac Surg. 2018 Apr 3. pii: S0003-4975(18)30414.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  7. HALMOS B
    Molecular Testing in Lung Cancer: Where to Draw the Line?
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0060.
    PubMed     Text format    

  8. ALTORKI NK
    Molecular Testing for Early Lung Cancer.
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0087.
    PubMed     Text format    


    BMC Cancer

  9. THRIUMANI R, Zakaria A, Hashim YZH, Jeffree AI, et al
    A study on volatile organic compounds emitted by in-vitro lung cancer cultured cells using gas sensor array and SPME-GCMS.
    BMC Cancer. 2018;18:362.
    PubMed     Text format     Abstract available


    Cancer Sci

  10. TANAKA I, Sato M, Kato T, Goto D, et al
    eIF2beta, a Subunit of Translation-Initiation Factor EIF2, Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer.
    Cancer Sci. 2018 Apr 6. doi: 10.1111/cas.13602.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  11. IOMMELLI F, De Rosa V, Terlizzi C, Monti M, et al
    Inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer detected by 18F-fluorothymidine.
    Clin Cancer Res. 2018 Apr 4. pii: 1078-0432.CCR-17-3657.
    PubMed     Text format     Abstract available

  12. FRANK R, Scheffler M, Merkelbach-Bruse S, Ihle MA, et al
    Clinical and pathological characteristics of KEAP1- and NFE2L2- mutated non-small cell lung carcinoma (NSCLC).
    Clin Cancer Res. 2018 Apr 3. pii: 1078-0432.CCR-17-3416.
    PubMed     Text format     Abstract available


    Int J Oncol

  13. ASAKA S, Yoshizawa A, Saito K, Kobayashi Y, et al
    Rapid point-of-care testing for epidermal growth factor receptor gene mutations in patients with lung cancer using cell-free DNA from cytology specimen supernatants.
    Int J Oncol. 2018 Mar 27. doi: 10.3892/ijo.2018.4334.
    PubMed     Text format     Abstract available

  14. ZHANG G, Xue P, Cui S, Yu T, et al
    Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4347.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  15. LOUIE AV
    A Small Window of Opportunity When Disease Is Limited in Extensive-Stage Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2018;101:7.
    PubMed     Text format    

  16. WANG HH, Wu ZQ, Qian D, Zaorsky NG, et al
    Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo.
    Int J Radiat Oncol Biol Phys. 2018;101:49-62.
    PubMed     Text format     Abstract available

  17. CHEN H, Laba JM, Boldt RG, Goodman CD, et al
    Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
    Int J Radiat Oncol Biol Phys. 2018;101:186-194.
    PubMed     Text format     Abstract available

  18. GORE EM
    Select Patients With "Limited" Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively.
    Int J Radiat Oncol Biol Phys. 2018;101:6-7.
    PubMed     Text format    


    J Cancer Res Clin Oncol

  19. AKTAS ON, Ozturk AB, Erman B, Erus S, et al
    Role of natural killer cells in lung cancer.
    J Cancer Res Clin Oncol. 2018 Apr 3. pii: 10.1007/s00432-018-2635.
    PubMed     Text format     Abstract available

  20. ELSAYAD K, Samhouri L, Scobioala S, Haverkamp U, et al
    Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?
    J Cancer Res Clin Oncol. 2018 Apr 5. pii: 10.1007/s00432-018-2640.
    PubMed     Text format     Abstract available


    J Clin Invest

  21. GONG K, Guo G, E Gerber D, Gao B, et al
    TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer.
    J Clin Invest. 2018 Apr 3. pii: 96148. doi: 10.1172/JCI96148.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  22. ISBELL JM, Jones DR, Li BT
    Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30707.
    PubMed     Text format    


    J Thorac Oncol

  23. GAJRA A, Zemla TJ, Jatoi A, Feliciano JL, et al
    Time-to-Treatment-Failure and Related Outcomes among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients.
    J Thorac Oncol. 2018 Mar 30. pii: S1556-0864(18)30254.
    PubMed     Text format     Abstract available


    Lung Cancer (Auckl)

  24. SYAHRUDDIN E, Wulandari L, Sri Muktiati N, Rima A, et al
    Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients.
    Lung Cancer (Auckl). 2018;9:25-34.
    PubMed     Text format     Abstract available


    N Engl J Med

  25. WEINSTOCK M, Vaidya A, El-Chemaly S, Godleski J, et al
    The Verge of Collapse.
    N Engl J Med. 2018;378:e18.
    PubMed     Text format    


    Oncogene

  26. PENTIMALLI F, Forte IM, Esposito L, Indovina P, et al
    RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.
    Oncogene. 2018 Apr 2. pii: 10.1038/s41388-018-0214.
    PubMed     Text format     Abstract available

  27. NEWMAN JH, Augeri DJ, NeMoyer R, Malhotra J, et al
    Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.
    Oncogene. 2018 Apr 6. pii: 10.1038/s41388-018-0156.
    PubMed     Text format     Abstract available


    Oncol Rep

  28. PARK BR, Lee SA, Moon SM, Kim CS, et al
    Anthricininduced caspasedependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human nonsmall lung cancer cells.
    Oncol Rep. 2018 Mar 27. doi: 10.3892/or.2018.6333.
    PubMed     Text format     Abstract available

  29. MA Y, Wu X, Xiu Z, Liu X, et al
    Cytochalasin H isolated from mangrovederived endophytic fungus induces apoptosis and inhibits migration in lung cancer cells.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6347.
    PubMed     Text format     Abstract available


    PLoS One

  30. FU M, Travier N, Martin-Sanchez JC, Martinez-Sanchez JM, et al
    Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
    PLoS One. 2018;13:e0195441.
    PubMed     Text format     Abstract available

  31. LEE EH, Park CH, Choi HJ, Kawala RA, et al
    Dexamethasone modified by gamma-irradiation as a novel anticancer drug in human non-small cell lung cancer.
    PLoS One. 2018;13:e0194341.
    PubMed     Text format     Abstract available

  32. ERNST AK, Putscher A, Samatov TR, Suling A, et al
    Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
    PLoS One. 2018;13:e0192525.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: